focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: -0.75 (-3.23%)
Spread: 1.00 (4.545%)
Open: 24.25
High: 24.50
Low: 22.50
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further information re Director's share transfer

12 Nov 2014 07:00

RNS Number : 7990W
Angle PLC
12 November 2014
 



For immediate release

12 November 2014

 

ANGLE plc

("ANGLE" or the "Company")

 

Further information re Director's share transfer

 

On 21 October 2014, the Company announced that Andrew Newland, Chief Executive of ANGLE, had agreed to transfer up to 3,500,000 ordinary shares of 10p each in the Company ("Ordinary Shares") as security for a loan facility in connection with his moving house (the "Announcement").

 

Following recent comments in the media relating to the Announcement, the Company wishes to provide the following information.

 

The agreement was entered into with Equity First Holdings LLC ("EFH") (the "Agreement") and, under the Agreement, which is a sale and repurchase agreement intended to provide financing to Andrew Newland, he transferred the legal and beneficial interest in 1,350,000 Ordinary Shares to EFH (the "transferred shares") in return for him receiving a payment from EFH of a sum equal to 62 per cent. of the three-day average mid-price per share (the "Starting Market Price") less a financing arrangement fee of 2 per cent.. Further details of the transfer made are set out below. As the legal and beneficial holder of the transferred shares, EFH may take any action it deems appropriate in relation to the transferred shares and is under no obligation to hold or retain the transferred shares.

 

On the maturity date of the Agreement (27 October 2016), Andrew Newland is contractually obliged to purchase the transferred shares or equivalent Ordinary Shares from EFH at a price equal to 67 per cent. of the Starting Market Price and EFH is contractually obliged to deliver the transferred shares or equivalent Ordinary Shares to Andrew Newland on payment.

 

If, prior to the maturity date, the value of the transferred shares falls to 49.6 per cent. or less of the Starting Market Price, Andrew Newland will be required to transfer further Ordinary Shares or provide cash to cover any difference.

 

The summary below is a clarification and correction of certain information contained in the Announcement. Andrew Newland remains interested in the transferred shares by reason of the repurchase obligation contained in the Agreement. Further announcements will be made if any further Ordinary Shares are transferred pursuant to the Agreement.

 

· Number of Ordinary Shares prior to transfer of shares under facility 7,054,686

· Number of Ordinary Shares transferred to EFH pursuant to the facility (and to be repurchased) to date 1,350,000

· Starting Market Price £0.851

· Number of Ordinary Shares with voting rights held after transactions and as a % of the Company 5,704,686 (12.61%)

· Total interest in Ordinary Shares and as a % of the Company(1) 7,054,686 (15.59%)

 

(1) As stated above, under the Agreement, Andrew Newland has agreed to repurchase the transferred shares or equivalent Ordinary Shares at the end of the two year period at a price calculated by reference to the Starting Market Price. For this reason he continues to have an interest in these Ordinary Shares and they are therefore included in his total interest in Ordinary Shares.

 

 

Garth Selvey, Chairman of ANGLE, commented: "Andrew has entered into this finance arrangement to bridge the purchase and renovation of a new house. Andrew believes strongly in the future value of ANGLE and does not want to sell his shares into the market. This facility enables him to return to his original position once the facility is repaid."

 

 

For further information:

 

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 

Cenkos Securities

Stephen Keys, Dr Christopher Golden (Nominated adviser)

Andy Roberts, Christian Hobart (Sales)

 

020 7397 8900

Buchanan

Mark Court, Sophie Cowles

020 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMMVZRGDZG
Date   Source Headline
26th Jan 20127:00 amRNSInterim Results
26th Jan 20127:00 amRNSNovocellus Update
26th Jan 20127:00 amRNSFundraising
23rd Jan 20127:01 amRNSParsortix Update
19th Jan 20127:00 amRNSNotice of Interim Results and Webcast
16th Dec 20117:00 amRNSParsortix Update - Validation for Lung Cancer
7th Dec 20117:00 amRNSParsortix Update
21st Nov 20117:00 amRNSShare Options
16th Nov 20117:00 amRNSNovocellus Update
15th Nov 20117:00 amRNSIssue of equity and Total Voting Rights
11th Nov 20117:00 amRNSValidation for Prostate Cancer
10th Nov 20117:00 amRNSChange of Adviser
7th Nov 20113:53 pmRNSACOLYTE BIOMEDICA COURT JUDGEMENT
31st Oct 20117:00 amRNSWORLD TECHNOLOGY NETWORK AWARD
27th Oct 20119:26 amRNSDirector's share transfer
24th Oct 20117:00 amRNSPortfolio Company Announces Strengthening Sales
12th Oct 20117:00 amRNSIssue of equity and Total Voting Rights
6th Oct 20112:33 pmRNSResults of 2011 Annual General Meeting
6th Oct 20117:00 amRNS2011 AGM Statement
5th Oct 20117:00 amRNSParsortix Update and Issue of Equity
4th Oct 20117:00 amRNSWEB CAST - Parsortix Update
28th Sep 20117:00 amRNSParsortix Update
15th Sep 20113:20 pmRNSHolding(s) in Company
14th Sep 20119:16 amRNSAnnual Report and Accounts and Notice of AGM
13th Sep 20113:54 pmRNSHolding(s) in Company
12th Sep 20112:53 pmRNSHolding(s) in Company
8th Sep 20115:26 pmRNSHolding(s) in Company
31st Aug 20112:44 pmRNSShare Options
26th Aug 20114:26 pmRNSHolding in Company
17th Aug 20117:00 amRNSIssue of equity and Total Voting Rights
28th Jul 20117:00 amRNSPreliminary Results
25th Jul 20117:00 amRNSGeomerics Announces Agreement with Epic Games
15th Jul 20117:00 amRNSConditional Fundraising
28th Jun 20117:00 amRNSParsortix Update
18th May 20117:00 amRNSAcolyte Biomedica Update
5th May 20117:00 amRNSParsortix Update
28th Apr 20117:00 amRNSGeomerics Corporate Deal Further Progress
14th Apr 20117:00 amRNSGeomerics progress
2nd Mar 20114:54 pmRNSDirector/PDMR Shareholding
1st Mar 20117:00 amRNSGeomerics Real-Status deal
27th Jan 20117:00 amRNSInterim Results
25th Jan 20119:00 amRNSNotice of Interim Results
12th Jan 20117:00 amRNSGeometrics Corporate Deal Update
7th Jan 20117:00 amRNSNeuroTargets Patent Grant
6th Dec 201011:38 amRNSHolding(s) in Company
17th Nov 201010:16 amRNSHolding(s) in Company
13th Oct 201010:06 amRNSDirector/PDMR Shareholding
13th Oct 201010:01 amRNSHolding(s) in Company
11th Oct 20101:34 pmRNSAcolyte Biomedica update
8th Oct 20107:00 amRNSPlacing Update and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.